Pathologic response of primary rectal cancer to oxaliplatin-based chemotherapy

Clinics in Colon and Rectal Surgery

Volumn 24, Issue 2, 2011, Pages 119-124

  Suárez, Javier ^a   Amat, Irene ^a   Vera, Ruth ^a   Balén, Enrique ^a   Gómez, Marisa ^a   Lera, Jose Miguel ^a  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

Author keywords

neoadjuvant chemotherapy; neoadjuvant radiotherapy; pathologic regression; Rectal cancer

Indexed keywords

EID: 79957484163     PISSN: 15310043     EISSN: 15309681     Source Type: Journal    
DOI: 10.1055/s-0031-1278409     Document Type: Article

References (13)

1. Nordlinger B, Sorbye H, Glimelius B et al, EORTC Gastro-Intestinal Tract Cancer Group Cancer Research UK Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO) Australasian Gastro-Intestinal Trials Group (AGITG) Fédération Francophone de Cancérologie Digestive (FFCD). Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet 2008 371 9617 1007-1016 (Pubitemid 351392040)
2. Sigurdsson H K., Krner H, Dahl O, Skarstein A, Sreide J A., Norwegian Rectal Cancer Group. Palliative surgery for rectal cancer in a national cohort. Colorectal Dis 2008 10 4 336-343 (Pubitemid 351524250)
3. Assumpcao L, Choti M, Gleizer A L. et al. Patterns of recurrence following liver resection for colorectal matastases: effect of primary rectal tumor site. Arch Surg 2008 143 8 743-749
4. Mentha G, Majno P E., Andres A, Rubbia-Brandt L, Morel P, Roth A D. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 2006 93 7 872-878 (Pubitemid 44035261)
5. Valentini V, Coco C, Picciocchi A et al. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients. Int J Radiat Oncol Biol Phys 2002 53 3 664-674 (Pubitemid 34626505)
6. Rödel C, Martus P, Papadoupolos T et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005 23 34 8688-8696 (Pubitemid 46211512)
7. Mandard A M., Dalibard F, Mandard J C. et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations. Cancer 1994 73 11 2680-2686 (Pubitemid 24166250)
8. Dworak O, Keilholz I, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997 12 1 19-23 (Pubitemid 27138353)
9. Ryan R, Gibbons D, Hyland J M. et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005 47 2 141-146 (Pubitemid 41113116)
10. Gervaz P, Rubbia-Brandt L, Andres A et al. Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes. Ann Surg Oncol 2010 17 10 2714-2719
11. Suárez J, Vera R, Balén E et al. Pathologic response assessed by Mandard grade is a better prognostic factor than down staging for disease-free survival after preoperative radiochemotherapy for advanced rectal cancer. Colorectal Dis 2008 10 6 563-568 (Pubitemid 351803062)
12. Dresen R C., Beets G L., Rutten H J. et al. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part I. Are we able to predict tumor confined to the rectal wall? Radiology 2009 252 1 71-80
13. Morcos B, Baker B, Al Masri M, Haddad H, Hashem S. Lymph node yield in rectal cancer surgery: effect of preoperative chemoradiotherapy. Eur J Surg Oncol 2010 36 4 345-349